Autologous mesenchymal stem cell-derived neural progenitors (MSC-NP)

mesenchymal stem cell-derived neural progenitors · Tisch Multiple Sclerosis Research Center of New York

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous mesenchymal stem cell-derived neural progenitors (MSC-NP), covering 2025-06-11 to 2025-06-11. Get the full timeline:

Most recent: Clinical Trial Update: Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis [Phase 2]

See pricing